N-(3-((4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)phenyl)-2,6-difluorobenzenesulfonamide

ID: ALA2386997

PubChem CID: 67219275

Max Phase: Preclinical

Molecular Formula: C24H23F2N5O2S

Molecular Weight: 483.54

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncnc2c1c(Cc1cccc(NS(=O)(=O)c3c(F)cccc3F)c1)cn2C1CCCC1

Standard InChI:  InChI=1S/C24H23F2N5O2S/c25-19-9-4-10-20(26)22(19)34(32,33)30-17-6-3-5-15(12-17)11-16-13-31(18-7-1-2-8-18)24-21(16)23(27)28-14-29-24/h3-6,9-10,12-14,18,30H,1-2,7-8,11H2,(H2,27,28,29)

Standard InChI Key:  KHXWUFRFWLVSHJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   36.5831  -13.4530    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   36.7587  -14.2591    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.3690  -13.7039    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.2030  -16.5923    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.2029  -17.4197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9182  -17.8317    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.9143  -16.1787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6302  -16.5869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6315  -17.4133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4179  -17.6675    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.9027  -16.9981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4159  -16.3303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6782  -18.4538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1944  -19.1220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6803  -19.7887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4646  -19.5325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4632  -18.7075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9108  -15.3537    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.6696  -15.5453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4763  -15.3725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0234  -15.9861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8294  -15.8138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0838  -15.0281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5260  -14.4145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7221  -14.5899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7770  -13.6286    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.8340  -12.6671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6395  -12.4964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8905  -11.7113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3351  -11.1001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5254  -11.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2782  -12.0640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1928  -13.1083    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   35.4730  -12.2439    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  1  3  2  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12  8  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
 10 13  1  0
  7 18  1  0
 12 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 24 26  1  0
 26  1  1  0
  1 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
 28 33  1  0
 32 34  1  0
M  END

Associated Targets(Human)

ERBB2 Tclin Epidermal growth factor receptor (487 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TEK Tclin Tyrosine-protein kinase TIE-2 (3348 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 483.54Molecular Weight (Monoisotopic): 483.1541AlogP: 4.80#Rotatable Bonds: 6
Polar Surface Area: 102.90Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 4.92CX Basic pKa: 7.07CX LogP: 3.60CX LogD: 3.74
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.41Np Likeness Score: -1.04

References

1. Arcari JT, Beebe JS, Berliner MA, Bernardo V, Boehm M, Borzillo GV, Clark T, Cohen BD, Connell RD, Frost HN, Gordon DA, Hungerford WM, Kakar SM, Kanter A, Keene NF, Knauth EA, Lagreca SD, Lu Y, Martinez-Alsina L, Marx MA, Morris J, Patel NC, Savage D, Soderstrom CI, Thompson C, Tkalcevic G, Tom NJ, Vajdos FF, Valentine JJ, Vincent PW, Wessel MD, Chen JM..  (2013)  Discovery and synthesis of novel 4-aminopyrrolopyrimidine Tie-2 kinase inhibitors for the treatment of solid tumors.,  23  (10): [PMID:23566514] [10.1016/j.bmcl.2013.03.012]

Source